Press Resease

Bioprocess Validation Market - By Process Component (Bioreactors and Filter Element), By Test Type (Integrity Testing, Extractables & Leachable, and Microbiology Testing), and By End-User (Biotechnology & Pharmaceutical Companies, and CDMO) - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2025

Published Date: 04-Sep-2019 Category: Medical Device Report Format : PDF Pages: 110 Report Code: ZMR-4671 Status : Published

Global bioprocess validation market in 2019 surpassed USD 179 million and is anticipated to be capitalized more than USD 369 million by 2025, with a CAGR of just more than 15% from 2019–2025.

Description

The global bioprocess validation market value was estimated at 179 (USD Million) in 2019 and is predicted to accrue a revenue of over 369 (USD Million) by 2025 registering a CAGR of over 15% during the period from 2019 to 2025. The report offers valuation and analysis of surface protection tapes market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, restraints, revenue estimates, avenues, current & emerging trends, and industry-validated market information. The report offers historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on value (USD Million).

Key Growth Drivers

With the concept of the right product, at the right time, and at the right place becoming a buzzword of the biopharmaceutical industry, the market for bioprocess validation is anticipated to gain traction over the forecast period. Furthermore, new drugs are being launched in the biopharmaceutical sector and this will require bioprocess validation in the foreseeable future.

Apparently, the feasibility of operations & processes is a few of the challenges faced by both the pharmaceutical and biopharmaceutical industries. Furthermore, bioprocess validation assists in reducing the daunting process in both these industries. This, in turn, is anticipated to steer the expansion of the bioprocess validation industry over the forthcoming years.

Our report also provides the current developments taking place in the industry along with the competitive strategies adopted by the market players to expand their profit margins and try to consolidate their position in the market or optimize their market share in this fragmented industry. Let us discuss the initiatives taken by some of the reputed brands of the industry.

Merck KgaA

In January 2020, Merck KgaA, a renowned German-based pharmaceutical firm, announced that it will set up a biotech development unit in Switzerland. As per the company sources, the investments in the unit are likely to hit €250 million. Reportedly, the key objective of the firm is to interweave biologics development & creation. Furthermore, the CEO of the healthcare unit of Merck declared that the setting up of the biotech development center is related to the focus of the firm’s operations on healthcare activities.

For the record, the pharmaceutical giant is likely to complete the project by 2021 and have it authenticated by 2022. The center will cover 169,000 square feet of area and the new construction is expected to have the capacity of accommodating a cross-functional team of 250 employees. Furthermore, the center will include new technologies for reducing the lead & cycle times and offer best process control, governance, and performance management practices to proficiently tackle the complexities of biomolecule drug development & delivery activities.

This, the strategic moves adopted by the reputed firms in the industry will have a major impact on the growth of the bioprocess validation industry over the years to come.

Some of the other key players profiled in the company apart from Merck KgaA include Cobetter Filtration Equipments Co., Ltd., SGS S.A., DOC S.r.l., Thermo Fisher Scientific, Toxikon Corporation, Sartorius Stedim Biotech, Eurofins Scientific, Pall Corporation, and MEISSNER FILTRATION PRODUCTS, INC.

The global bioprocess validation market is segmented as follows:

By Test Type

  • Extractables/Leachables Testing Services
  • Microbiological Testing Services
    • Large-Scale Eukaryotic Cell Culture
    • Virus Production And Purification
    • Electron Microscopy
  • Integrity Testing Services
  • Physiochemical Testing Services
  • Compatibility Testing Services
  • Others Testing Services (Bacterial Retention Testing Services, and Adsorption Testing Services)

By Process Component

  • Filter elements
  • Media containers and bags
  • Freezing and Thawing process bags
  • Mixing Systems
  • Bioreactors
  • Transfer systems
  • Others (Tubing, Connectors, Samplers)

By End User

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Development & Manufacturing Organizations
  • Others (CROs, Research Laboratories and Institutes)

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Bioprocess Validation Market, 2016–2025 (USD Million)
    • 2.2. Bioprocess Validation Market: Snapshot
  • Chapter 3. Global Bioprocess Validation Market– Industry Analysis
    • 3.1. Bioprocess Validation Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Need for enhancing governance, improving process contrul activities, and performance management for effectively tackling process complexity
      • 3.2.2. Sheer requirement of firms to position them in terms of speeding of drugs to market & fulfillment of vulatile product demand through flexible response
      • 3.2.3. Rise in demand for quality & regulatory compliance
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Process Component
      • 3.4.2. Market attractiveness analysis By Test Type
      • 3.4.3. Market attractiveness analysis By End User
      • 3.4.4. Market attractiveness analysis by Region
  • Chapter 4. Global Bioprocess Validation Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Bioprocess Validation Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New bioprocess launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Bioprocess Validation Market– Process Component Analysis
    • 5.1. Global Bioprocess Validation Market overview: By Process Component
      • 5.1.1. Global Bioprocess Validation Market share, By Process Component,2018 and 2025
    • 5.2. Bioreactors
      • 5.2.1. Global Bioprocess Validation Market by Bioreactors, 2016–2025 (USD Million)
    • 5.3. Filter Element
      • 5.3.1. Global Bioprocess Validation Market by Filter Element, 2016–2025 (USD Million)
  • Chapter 6. Global Bioprocess Validation Market– Test Type Analysis
    • 6.1. Global Bioprocess Validation Market overview: By Test Type
      • 6.1.1. Global Bioprocess Validation Market share, By Test Type, 2018 and 2025
    • 6.2. Integrity Testing
      • 6.2.1. Global Bioprocess Validation Market By Integrity Testing, 2016–2025 (USD Million)
    • 6.3. Extractables and Leachables
      • 6.3.1. Global Bioprocess Validation Market By Extractables and Leachables, 2016–2025 (USD Million)
    • 6.4. Microbiulogy Testing
      • 6.4.1. Global Bioprocess Validation Market By Microbiulogy Testing, 2016–2025 (USD Million)
  • Chapter 7. Global Bioprocess Validation Market– End User Analysis
    • 7.1. Global Bioprocess Validation Market overview: By End User
      • 7.1.1. Global Bioprocess Validation Market share, By End User, 2018 and 2025
    • 7.2. Biotechnulogy & Pharmaceutical Companies
      • 7.2.1. Global Bioprocess Validation Market By Biotechnulogy & Pharmaceutical Companies, 2016–2025 (USD Million)
    • 7.3. CDMO
      • 7.3.1. Global Bioprocess Validation Market By CDMO, 2016–2025 (USD Million)
  • Chapter 8. Company Profiles
    • 8.1. SGS S.A.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Test Type Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Merck KGaA
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Test Type Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. Sartorius Stedim Biotech
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Test Type Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. Eurofins Scientific
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Test Type Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. Cobetter Filtration Equipments Co, Ltd.
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Test Type Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Developments
    • 8.6. Pall Corporation
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Test Type Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Developments
    • 8.7. DOC S.r.l.
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Test Type Portfolio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Developments
    • 8.8. Toxikon Corporation
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Test Type Portfolio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Developments
    • 8.9. Thermo Fisher Scientific
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Test Type Portfolio
      • 8.9.4. Business
      • 8.9.5. StrategyRecent Developments
    • 8.10. MEISSNER FILTRATION PRODUCTS, INC.
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Test Type Portfolio
      • 8.10.4. Business Strategy
      • 8.10.5. Recent Developments

Methodology

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com